United States · FDA National Drug Code directory
Plasbumin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13533-692_38864ce1-9eaf-4d04-bfca-39205b0f1504
- Product NDC
- 13533-692
- Form
- SOLUTION
- Composition / generic term
- Albumin (Human)
- Labeler
- GRIFOLS USA, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19940926
- Source listing expiry
- 20261231
Source-listed ingredients
- ALBUMIN HUMAN — 5 g/20mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL in 1 CARTON (13533-692-16) / 20 mL in 1 VIAL (13533-692-17) · 13533-692-16
- 1 VIAL in 1 CARTON (13533-692-20) / 50 mL in 1 VIAL (13533-692-21) · 13533-692-20
- 1 VIAL in 1 CARTON (13533-692-71) / 100 mL in 1 VIAL (13533-692-72) · 13533-692-71
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →